New research found that SGLT2 inhibitors reduce all-cause mortality and major adverse kidney events by 18% and 22%, respectively, in adults aged 80 years or older with CKD. However, these medications may also increase the risk of specific cardiac events and acute kidney injury in this demographic.
A Rutgers study found that 1 in 3 young adults (18-29 years) use AI for substance-use information, primarily seeking risks and consequences. The study highlights the need for research on how young adults interpret and understand AI outputs on substance use, with implications for public health.
A new study reveals that airflow can cool UV-C lamps, altering their output and reducing airborne particle exposure time. Researchers found that higher-power lamps maintained stable output, while lower-power lamps were more sensitive to airflow and temperature fluctuations.
A new immunotherapy combination extends survival in patients with advanced endometrial cancer, with patients receiving durvalumab plus olaparib living almost one year longer than those treated with chemotherapy alone. The treatment was particularly effective for patients with mismatch repair proficient tumors, who have traditionally ha...